Cite
HARVARD Citation
Punekar, Y. et al. (2015). Cost-effectiveness of umeclidinium/vilanterol combination therapy compared to tiotropium monotherapy among symptomatic patients with chronic obstructive pulmonary disease in the UK. Cost effectiveness and resource allocation. 13 (1), pp. 1-8. [Online].